Orthofix International N.V. (OFIX) Holdings Raised by Citadel Advisors LLC
Citadel Advisors LLC boosted its position in Orthofix International N.V. (NASDAQ:OFIX) by 83.2% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 11,313 shares of the medical device company’s stock after acquiring an additional 5,138 shares during the period. Citadel Advisors LLC owned 0.06% of Orthofix International worth $535,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently made changes to their positions in OFIX. Bank of America Corp DE grew its holdings in Orthofix International by 834.2% in the 1st quarter. Bank of America Corp DE now owns 28,838 shares of the medical device company’s stock worth $1,100,000 after acquiring an additional 25,751 shares during the last quarter. State Street Corp boosted its stake in shares of Orthofix International by 27.0% during the 1st quarter. State Street Corp now owns 462,479 shares of the medical device company’s stock valued at $17,640,000 after purchasing an additional 98,212 shares in the last quarter. Aperio Group LLC boosted its stake in shares of Orthofix International by 23.4% during the 2nd quarter. Aperio Group LLC now owns 15,316 shares of the medical device company’s stock valued at $712,000 after purchasing an additional 2,902 shares in the last quarter. Municipal Employees Retirement System of Michigan bought a new stake in shares of Orthofix International during the 2nd quarter valued at about $196,000. Finally, Texas Permanent School Fund boosted its stake in shares of Orthofix International by 41.5% during the 2nd quarter. Texas Permanent School Fund now owns 13,174 shares of the medical device company’s stock valued at $612,000 after purchasing an additional 3,867 shares in the last quarter. 94.61% of the stock is currently owned by institutional investors and hedge funds.
In related news, CEO Brad Mason sold 5,000 shares of Orthofix International stock in a transaction dated Tuesday, November 28th. The shares were sold at an average price of $53.48, for a total transaction of $267,400.00. Following the completion of the transaction, the chief executive officer now directly owns 183,053 shares of the company’s stock, valued at approximately $9,789,674.44. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Luke T. Faulstick sold 4,800 shares of Orthofix International stock in a transaction dated Monday, November 6th. The shares were sold at an average price of $51.22, for a total transaction of $245,856.00. Following the transaction, the director now directly owns 7,729 shares of the company’s stock, valued at $395,879.38. The disclosure for this sale can be found here. Company insiders own 5.60% of the company’s stock.
Orthofix International N.V. (NASDAQ OFIX) opened at $51.94 on Tuesday. Orthofix International N.V. has a 12-month low of $32.51 and a 12-month high of $54.73. The stock has a market cap of $963.51, a PE ratio of 34.54, a P/E/G ratio of 2.62 and a beta of 0.14.
Orthofix International (NASDAQ:OFIX) last issued its quarterly earnings results on Monday, October 30th. The medical device company reported $0.42 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.41 by $0.01. Orthofix International had a net margin of 0.33% and a return on equity of 10.26%. The company had revenue of $105.30 million during the quarter, compared to analysts’ expectations of $100.67 million. During the same period last year, the company posted $0.36 EPS. Orthofix International’s revenue was up 6.9% on a year-over-year basis. analysts anticipate that Orthofix International N.V. will post 1.61 EPS for the current year.
Orthofix International Company Profile
Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim.
Want to see what other hedge funds are holding OFIX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Orthofix International N.V. (NASDAQ:OFIX).
Receive News & Ratings for Orthofix International N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix International N.V. and related companies with MarketBeat.com's FREE daily email newsletter.